Evidence map›Paper›PMID 38847170›Full record

ReviewCurrent drug discovery technologies2025

Understanding the Potential of CBD for Health Benefits: An Overview.

Ivan Santos, Maria Beatriz Prior Pinto Oliveira, Ana Casas, Javier Fidalgo Lopez, Hugo Almeida

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current drug discovery technologies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ivan SantosREQUIMTE/ LAQV, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Porto, 4050-313, Portugal.ORCID 0009-0004-4552-2360
Maria Beatriz Prior Pinto OliveiraREQUIMTE/ LAQV, Departamento de Ciências Químicas, Faculdade de Farmácia, Universidade do Porto, Porto, 4050-313, Portugal.ORCID 0000-0002-6767-6596
Ana CasasMesosystem Investigação & Investimentos by Spinpark, Barco, Guimarães, 4805-017, Portugal.ORCID 0009-0002-5420-3439
Javier Fidalgo LopezMesosystem Investigação & Investimentos by Spinpark, Barco, Guimarães, 4805-017, Portugal.ORCID 0000-0002-7411-7231
Hugo AlmeidaMesosystem Investigação & Investimentos by Spinpark, Barco, Guimarães, 4805-017, Portugal.ORCID 0000-0002-0799-2335

Funding

Ministério para a Ciência e Tecnologia - FCT Fundação para a Ciência e a Tecnologia UIDP/50006/2020
6 · The paper itself

Abstract

Cannabinoids are compounds with increasing scientific interest, particularly due to their interaction with the endocannabinoid system via CBR1 and CBR2 receptors. They can interfere with appetite, pain, and sleep or develop mood changes in the individual. Cannabidiol (CBD) is a well-known cannabinoid with potential benefits, including reducing epilepsy seizures, alleviating anxiety and obsessive-compulsive disorder (OCD) symptoms, aiding in Tourette Syndrome (a neurodevelopmental disorder), depression, sleep disorders, and promising in the treatment of cancer, pain relief, and heart health. Although generally safe, CBD can have side effects, including drug metabolism interference, fertility, and liver function. In addition, it can be administered by oral, sublingual, transdermal, or inhalation via each one with different bioavailability. The application of nanotechnology, specifically through colloidal carrier systems, holds promising potential for maximizing CBD's efficacy and pharmacological profile. There are reported CBD extraction methods using ethanol, carbon dioxide, deionised water, and non-polar oils like olive or coconut oil. Green extraction methods have gained popularity due to their higher yields, shorter extraction time, and reduced costs. A specific dose with the desired effects is challenging due to individual factors, with most studies suggesting a range between less than 1 and 50 mg/kg/d. This review aims to explore the principles of CBD-based products development, focusing on extraction methods and purification processes of this cannabinoid for tinctures, topicals, and other pharmaceutical forms, as well as further research to attain the objectives.

Indexed as

CannabidiolAnimalsHumansCannabidiolbioavailabilityCannabidiolcannabinoidsCBR1 and CBR2 receptornanotechnologyobsessive-compulsive disorder.

Identifiers

PMID38847170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.